HEADER TRANSFERASE-TRANSFERASE INHIBITOR 13-SEP-19 6UBW TITLE MET TYROSINE KINASE INHIBITION ENHANCES THE ANTITUMOR EFFICACY OF AN TITLE 2 HGF ANTIBODY COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 1023-1360; COMPND 5 SYNONYM: HGF RECEPTOR, HGF/SF RECEPTOR, PROTO-ONCOGENE C-MET, SCATTER COMPND 6 FACTOR RECEPTOR, SF RECEPTOR, TYROSINE-PROTEIN KINASE MET; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MET; SOURCE 6 EXPRESSION_SYSTEM: BACULOVIRUS EXPRESSION VECTOR PFASTBAC1-HM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 274590; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1-HM KEYWDS MET, TYROSINE KINASE, INHIBITOR, ANTITUMOR, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX, TRANSFERASE-TRANSFERASE INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR I.D.HOFFMAN,J.D.LAWSON REVDAT 2 25-AUG-21 6UBW 1 JRNL REVDAT 1 12-FEB-20 6UBW 0 SPRSDE 12-FEB-20 6UBW 5UAF JRNL AUTH P.J.FARRELL,J.MATUSZKIEWICZ,D.BALAKRISHNA,S.PANDYA, JRNL AUTH 2 M.S.HIXON,R.KAMRAN,S.CHU,J.D.LAWSON,K.OKADA,A.HORI, JRNL AUTH 3 A.MIZUTANI,H.IWATA,R.DE JONG,B.HIBNER,P.VINCENT JRNL TITL MET TYROSINE KINASE INHIBITION ENHANCES THE ANTITUMOR JRNL TITL 2 EFFICACY OF AN HGF ANTIBODY. JRNL REF MOL.CANCER THER. V. 16 1269 2017 JRNL REFN ESSN 1538-8514 JRNL PMID 28341789 JRNL DOI 10.1158/1535-7163.MCT-16-0771 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0135 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 21568 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1127 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1459 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.08 REMARK 3 BIN R VALUE (WORKING SET) : 0.2540 REMARK 3 BIN FREE R VALUE SET COUNT : 74 REMARK 3 BIN FREE R VALUE : 0.3320 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2364 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 166 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.28 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.11000 REMARK 3 B22 (A**2) : -0.50000 REMARK 3 B33 (A**2) : 2.61000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.181 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.158 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.123 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.885 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.932 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2461 ; 0.007 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2360 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3337 ; 1.147 ; 1.976 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5433 ; 0.881 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 291 ; 5.268 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 102 ;34.943 ;23.529 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 421 ;11.815 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 11 ;13.674 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 368 ; 0.066 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2736 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 559 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1030 A 1360 REMARK 3 ORIGIN FOR THE GROUP (A): 9.5932 -0.8695 16.3549 REMARK 3 T TENSOR REMARK 3 T11: 0.1337 T22: 0.0715 REMARK 3 T33: 0.0130 T12: -0.0219 REMARK 3 T13: 0.0122 T23: 0.0224 REMARK 3 L TENSOR REMARK 3 L11: 1.8152 L22: 2.6301 REMARK 3 L33: 2.2344 L12: 0.4888 REMARK 3 L13: -0.6099 L23: -0.0390 REMARK 3 S TENSOR REMARK 3 S11: 0.0591 S12: -0.3471 S13: -0.1192 REMARK 3 S21: 0.5055 S22: -0.0916 S23: 0.0648 REMARK 3 S31: 0.2686 S32: 0.0243 S33: 0.0325 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 6UBW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-SEP-19. REMARK 100 THE DEPOSITION ID IS D_1000244326. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9765 REMARK 200 MONOCHROMATOR : SI(220) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22773 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : 0.10300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.03 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.40 REMARK 200 R MERGE FOR SHELL (I) : 0.62200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% ISOPROPANOL, 10% PEG5000 MME, 0.06 REMARK 280 M HEPES SODIUM, 0.04 M HEPES, PH 7.5, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.20700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 80.30350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.69900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 80.30350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.20700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 23.69900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 130 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14710 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1019 REMARK 465 ALA A 1020 REMARK 465 MET A 1021 REMARK 465 GLY A 1022 REMARK 465 SER A 1023 REMARK 465 GLN A 1024 REMARK 465 VAL A 1025 REMARK 465 GLN A 1026 REMARK 465 TYR A 1027 REMARK 465 PRO A 1028 REMARK 465 LEU A 1029 REMARK 465 LEU A 1035A REMARK 465 THR A 1035B REMARK 465 SER A 1035C REMARK 465 GLY A 1035D REMARK 465 ASP A 1035E REMARK 465 SER A 1035F REMARK 465 ASP A 1035G REMARK 465 ILE A 1035H REMARK 465 SER A 1035I REMARK 465 SER A 1035J REMARK 465 PRO A 1035K REMARK 465 LEU A 1035L REMARK 465 LEU A 1035M REMARK 465 GLN A 1035N REMARK 465 ASN A 1035O REMARK 465 THR A 1035P REMARK 465 VAL A 1035Q REMARK 465 HIS A 1035R REMARK 465 ILE A 1035S REMARK 465 ASP A 1035T REMARK 465 LEU A 1035U REMARK 465 SER A 1035V REMARK 465 ALA A 1035W REMARK 465 LEU A 1035X REMARK 465 ASP A 1099 REMARK 465 ASN A 1100 REMARK 465 ASP A 1101 REMARK 465 ARG A 1114 REMARK 465 ILE A 1115 REMARK 465 THR A 1116 REMARK 465 ASP A 1117 REMARK 465 ARG A 1148 REMARK 465 SER A 1149 REMARK 465 GLU A 1150 REMARK 465 GLY A 1151 REMARK 465 SER A 1152 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A1103 135.64 68.29 REMARK 500 ARG A1203 -11.60 78.68 REMARK 500 ASP A1204 41.96 -152.46 REMARK 500 ALA A1221 -155.48 -131.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1666 DISTANCE = 6.91 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 84S A 1401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 1402 DBREF 6UBW A 1024 1360 UNP P08581 MET_HUMAN 1023 1360 SEQADV 6UBW GLY A 1019 UNP P08581 EXPRESSION TAG SEQADV 6UBW ALA A 1020 UNP P08581 EXPRESSION TAG SEQADV 6UBW MET A 1021 UNP P08581 EXPRESSION TAG SEQADV 6UBW GLY A 1022 UNP P08581 EXPRESSION TAG SEQADV 6UBW SER A 1023 UNP P08581 EXPRESSION TAG SEQRES 1 A 343 GLY ALA MET GLY SER GLN VAL GLN TYR PRO LEU THR ASP SEQRES 2 A 343 MET SER PRO ILE LEU THR SER GLY ASP SER ASP ILE SER SEQRES 3 A 343 SER PRO LEU LEU GLN ASN THR VAL HIS ILE ASP LEU SER SEQRES 4 A 343 ALA LEU ASN PRO GLU LEU VAL GLN ALA VAL GLN HIS VAL SEQRES 5 A 343 VAL ILE GLY PRO SER SER LEU ILE VAL HIS PHE ASN GLU SEQRES 6 A 343 VAL ILE GLY ARG GLY HIS PHE GLY CYS VAL TYR HIS GLY SEQRES 7 A 343 THR LEU LEU ASP ASN ASP GLY LYS LYS ILE HIS CYS ALA SEQRES 8 A 343 VAL LYS SER LEU ASN ARG ILE THR ASP ILE GLY GLU VAL SEQRES 9 A 343 SER GLN PHE LEU THR GLU GLY ILE ILE MET LYS ASP PHE SEQRES 10 A 343 SER HIS PRO ASN VAL LEU SER LEU LEU GLY ILE CYS LEU SEQRES 11 A 343 ARG SER GLU GLY SER PRO LEU VAL VAL LEU PRO TYR MET SEQRES 12 A 343 LYS HIS GLY ASP LEU ARG ASN PHE ILE ARG ASN GLU THR SEQRES 13 A 343 HIS ASN PRO THR VAL LYS ASP LEU ILE GLY PHE GLY LEU SEQRES 14 A 343 GLN VAL ALA LYS GLY MET LYS TYR LEU ALA SER LYS LYS SEQRES 15 A 343 PHE VAL HIS ARG ASP LEU ALA ALA ARG ASN CYS MET LEU SEQRES 16 A 343 ASP GLU LYS PHE THR VAL LYS VAL ALA ASP PHE GLY LEU SEQRES 17 A 343 ALA ARG ASP MET TYR ASP LYS GLU TYR TYR SER VAL HIS SEQRES 18 A 343 ASN LYS THR GLY ALA LYS LEU PRO VAL LYS TRP MET ALA SEQRES 19 A 343 LEU GLU SER LEU GLN THR GLN LYS PHE THR THR LYS SER SEQRES 20 A 343 ASP VAL TRP SER PHE GLY VAL LEU LEU TRP GLU LEU MET SEQRES 21 A 343 THR ARG GLY ALA PRO PRO TYR PRO ASP VAL ASN THR PHE SEQRES 22 A 343 ASP ILE THR VAL TYR LEU LEU GLN GLY ARG ARG LEU LEU SEQRES 23 A 343 GLN PRO GLU TYR CYS PRO ASP PRO LEU TYR GLU VAL MET SEQRES 24 A 343 LEU LYS CYS TRP HIS PRO LYS ALA GLU MET ARG PRO SER SEQRES 25 A 343 PHE SER GLU LEU VAL SER ARG ILE SER ALA ILE PHE SER SEQRES 26 A 343 THR PHE ILE GLY GLU HIS TYR VAL HIS VAL ASN ALA THR SEQRES 27 A 343 TYR VAL ASN VAL LYS HET 84S A1401 33 HET CL A1402 1 HETNAM 84S N-(6-{DIFLUORO[6-(1-METHYL-1H-PYRAZOL-4-YL)[1,2, HETNAM 2 84S 4]TRIAZOLO[4,3-A]PYRIDIN-3-YL]METHYL}IMIDAZO[1,2- HETNAM 3 84S B]PYRIDAZIN-2-YL)CYCLOPROPANECARBOXAMIDE HETNAM CL CHLORIDE ION FORMUL 2 84S C21 H17 F2 N9 O FORMUL 3 CL CL 1- FORMUL 4 HOH *166(H2 O) HELIX 1 AA1 PRO A 1060 VAL A 1066 1 7 HELIX 2 AA2 GLY A 1072 SER A 1074 5 3 HELIX 3 AA3 GLY A 1119 PHE A 1134 1 16 HELIX 4 AA4 ASP A 1164 ASN A 1171 1 8 HELIX 5 AA5 THR A 1177 LYS A 1198 1 22 HELIX 6 AA6 ALA A 1206 ARG A 1208 5 3 HELIX 7 AA7 PHE A 1223 ARG A 1227 5 5 HELIX 8 AA8 ASP A 1231 TYR A 1235 5 5 HELIX 9 AA9 PRO A 1246 MET A 1250 5 5 HELIX 10 AB1 ALA A 1251 GLN A 1258 1 8 HELIX 11 AB2 THR A 1261 THR A 1278 1 18 HELIX 12 AB3 ASP A 1291 GLN A 1298 1 8 HELIX 13 AB4 PRO A 1309 TRP A 1320 1 12 HELIX 14 AB5 LYS A 1323 ARG A 1327 5 5 HELIX 15 AB6 SER A 1329 THR A 1343 1 15 SHEET 1 AA1 5 LEU A1076 ARG A1086 0 SHEET 2 AA1 5 GLY A1090 LEU A1097 -1 O VAL A1092 N GLY A1085 SHEET 3 AA1 5 ILE A1105 LEU A1112 -1 O VAL A1109 N TYR A1093 SHEET 4 AA1 5 LEU A1154 PRO A1158 -1 O LEU A1157 N ALA A1108 SHEET 5 AA1 5 GLY A1144 CYS A1146 -1 N CYS A1146 O LEU A1154 SHEET 1 AA2 2 CYS A1210 LEU A1212 0 SHEET 2 AA2 2 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 SHEET 1 AA3 2 SER A1236 VAL A1237 0 SHEET 2 AA3 2 LYS A1244 LEU A1245 -1 O LEU A1245 N SER A1236 SITE 1 AC1 16 ILE A1084 VAL A1092 ALA A1108 LEU A1157 SITE 2 AC1 16 PRO A1158 TYR A1159 MET A1160 LYS A1161 SITE 3 AC1 16 GLY A1163 ASP A1164 ARG A1208 MET A1211 SITE 4 AC1 16 ALA A1221 ASP A1222 ALA A1226 TYR A1230 SITE 1 AC2 4 LYS A1179 GLY A1346 GLU A1347 HIS A1348 CRYST1 42.414 47.398 160.607 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023577 0.000000 0.000000 0.00000 SCALE2 0.000000 0.021098 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006226 0.00000